Related Experiment Video
Updated: Apr 20, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
Identifying statin-associated autoimmune necrotizing myopathy
Jemima Albayda1, Lisa Christopher-Stine2
1Division of Rheumatology, Department of Medicine, and Instructor in Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract:
Statins up-regulate expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis and the major target of autoantibodies in statin-associated immune-mediated necrotizing myopathy. As muscle cells regenerate, they express high levels of HMGCR, which may sustain the immune response even after statin therapy is stopped. Awareness of this entity will help physicians who prescribe statins to take action to limit the associated morbidity.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis ll: Pathophysiology
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Satellite Stem Cells and Muscular Dystrophy
Myocarditis III: Medical Management
